Heat Shock Protein, Citrullinated Antigen and Dendritic Cell Interactions
热休克蛋白、瓜氨酸抗原和树突状细胞相互作用
基本信息
- 批准号:7617038
- 负责人:
- 金额:$ 6.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-23 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntigen-Presenting CellsAntigensAutoantigensAutoimmune ProcessCell CommunicationCo-ImmunoprecipitationsCommon EpitopeComplexConfocal MicroscopyDendritic CellsDiseaseEpitopesEventFamilyFibrinFibrinogenGoalsHLA-DR1 AntigenHLA-DR4 AntigenHeat Stress DisordersHeat shock proteinsHeat-Shock Proteins 70Immune responseImmune systemIn VitroInflammatoryJointsLinkLymphocytePatientsPeptidesProcessProteinsResearchRheumatoid ArthritisSerumStagingSurface Plasmon ResonanceSynovial FluidTechniquesTherapeuticTimebiological adaptation to stresseffective therapyimmunopathologyresponsetraffickinguptake
项目摘要
DESCRIPTION (provided by applicant):
The long-term objective of this research is to develop highly directed and long-lasting therapy for rheumatoid arthritis (RA). The specific aims are to, for the first time: 1) Study physical associations between heat shock protein (HSP70) and citrullinated-fibrinogen 2) Demonstrate mechanism of delivery of cit-fibrinogen into immature dendritic cells (DC). The recognition that cit-proteins (especially cit-fibrinogen) are key auto-antigens (Ags) initiating and perpetuating immunopathology in RA may represent a huge step toward achieving more effective therapy. To date, however, many of the events related to the handling of cit-Ags are unknown, including mechanisms of cit-autoAg uptake/processing by antigen presenting cells such as DC. The hypothesis is that in RA, citrullinated Ags such as cit-fibrinogen are transported via HSP into immature DC to activate autoimmune lymphocyte responses. In RA, HSP are highly abundant and likely to facilitate the transport of auto-Ags into immature DC. Because citrullination of proteins results in unfolding and partial denaturing, citproteins are prime candidates for association with HSP, which partner with proteins in non-native states. Emphasis will be placed on studying inducible HSP70 and cit-fibrin, which are specifically elevated in RA synovial fluid (SF) vs non-RA SF and considered key self-cit-Ags in RA, resp. In Aim 1, HSP70-cit-fibrinogen interactions will be studied using surface plasmon resonance (SPR) and co-immunoprecipitation (IP) techniques. For SPR, purified proteins will be used. HSP70-cit-fibinogen complexes present in RA SF, RA serum, non-RA SF and normal serum will be revealed by IP. In Aim 2, immature DC will be primed in vitro to undergo an inflammatory/heat stress response under precise conditions present in the RA joint. After the addition of cit-fibrinogen, uptake/intracellular trafficking of cit-fibinogen will be assessed by IP and confocal microscopy. Due to the increased affinity of cit-Ags to HLA-DR4, studies of cit-fibrinogen-HLA-DR interactions and cit-fibrinogen uptake in DC prepared from RA patients expressing the common epitope will be included. These studies will employ synthetic cit-fibrinogen 10mer peptides (containing cit-epitopes) and native fib peptides and purified HLA-DR4 and HLA-DR1 (non RA linked). Understanding how key self-antigens in RA are handled by the immune system at the earliest stages of the autoimmune process may reveal a universal disease mechanism that can be specifically interrupted, before the onset of severe disease activity.
描述(由申请人提供):
这项研究的长期目标是开发针对类风湿关节炎(RA)高度定向和长期疗法。具体目的是,第一次:1)研究热休克蛋白(HSP70)和瓜氨基氨基纤维蛋白原之间的物理关联2)证明了将柠檬纤维蛋白原传递到未成熟的树突状细胞(DC)中的机制。认识到,柠檬蛋白(尤其是柠檬纤维蛋白原)是关键的自动抗原(AGS)在RA中引发和永久性免疫病理学可能是朝着实现更有效治疗的巨大一步。然而,迄今为止,与CIT-AGS处理有关的许多事件尚不清楚,包括通过抗原呈递细胞(例如DC)对CIT-AutoAg摄取/加工的机制。假设是,在RA中,将Citruplinated AG(例如Cit-纤维蛋白原)通过HSP运输到未成熟的DC中,以激活自身免疫性淋巴细胞反应。在RA中,HSP高度丰富,并且很可能促进自动速度转运到未成熟的DC中。由于蛋白质的柠檬化会导致展开和部分变性,因此柠檬蛋白是与HSP相关的主要候选者,HSP与非本地状态的蛋白质合作。重点将放在研究诱导HSP70和CIT-纤维蛋白上,它们在RA滑液(SF)与非RA SF中的特异性升高,并被认为是RA中的关键自动cit-ags,resp。在AIM 1中,将使用表面等离子体共振(SPR)和共免疫沉淀(IP)技术研究HSP70-CIT-纤维蛋白原相互作用。对于SPR,将使用纯化的蛋白质。 RA SF,RA血清,非RA SF和正常血清中存在的HSP70-CIT纤维纤维组合物将由IP揭示。在AIM 2中,未成熟的DC将在体外启动,以在RA关节中存在的精确条件下进行炎症/热应激反应。添加了柠檬纤维蛋白原后,将通过IP和共聚焦显微镜评估CIT纤维蛋白原的摄取/细胞内运输。由于CIT-AGS与HLA-DR4的亲和力增加,将包括对表达公共表位的RA患者制备的DC中CIT-FIRBILIN HALA-DR相互作用和CIT-纤维蛋白原吸收的研究。这些研究将采用合成的CIT-纤维蛋白原10mer肽(含有柠檬含量)和天然FIB肽以及纯化的HLA-DR4和HLA-DR1(非RA链接)。在自身免疫过程的最早阶段,了解RA中的关键自我抗原是如何处理的,可能会揭示出一种普遍的疾病机制,该机制可能会在严重疾病活动开始之前特异性中断。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frances Ivette Santiago-Schwarz其他文献
Frances Ivette Santiago-Schwarz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frances Ivette Santiago-Schwarz', 18)}}的其他基金
Heat Shock Protein, Citrullinated Antigen and Dendritic Cell Interactions
热休克蛋白、瓜氨酸抗原和树突状细胞相互作用
- 批准号:
7429755 - 财政年份:2007
- 资助金额:
$ 6.79万 - 项目类别:
Heat Shock Protein, Citrullinated Antigen and Dendritic Cell Interactions
热休克蛋白、瓜氨酸抗原和树突状细胞相互作用
- 批准号:
7249980 - 财政年份:2007
- 资助金额:
$ 6.79万 - 项目类别:
相似国自然基金
光调控机体获得性免疫应答治疗肿瘤的效应和机制探讨
- 批准号:62005085
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
具有温度/pH双重响应和甘露糖受体靶向功能的微凝胶疫苗
- 批准号:51903233
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于DNA自组装技术的人工抗原呈递细胞设计构建及其免疫功能评价
- 批准号:21907073
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
高同型半胱氨酸血症放大高脂引起动脉粥样硬化早期发病--管周脂肪的抗原呈递作用
- 批准号:91439206
- 批准年份:2014
- 资助金额:270.0 万元
- 项目类别:重大研究计划
内淋巴囊上皮细胞在内耳免疫调控作用中的分子机制研究
- 批准号:81371084
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 6.79万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 6.79万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 6.79万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 6.79万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 6.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)